• Homoharringtonine Rapidly Clears SARS-CoV-2 in Preclinical M

  2026-05-02

  The referenced study demonstrates that homoharringtonine, a cytotoxic alkaloid previously established in leukemia research, achieves rapid SARS-CoV-2 clearance in both preclinical and early clinical settings. The findings suggest a viable, protein synthesis-targeted strategy for future coronavirus outbreak preparedness, with implications for cross-domain antiviral and oncology workflows.

• CIAV VP2-CK2α Interaction: Mechanisms and Antiviral Targetin

  2026-05-01

  This study reveals that chicken infectious anemia virus (CIAV) requires the host kinase CK2α for efficient replication via a direct interaction with the viral VP2 protein at Ser182 and Asp183. Disruption or inhibition of this interaction impairs viral replication and pathogenesis, highlighting CK2α as a promising target for antiviral intervention.

• SU6656 Src Tyrosine Kinases Inhibitor for Platelet and Cance

  2026-04-30

  SU6656, a selective Src tyrosine kinases inhibitor from APExBIO, empowers researchers to optimize platelet differentiation from hiPSCs and enhance radiotherapy efficacy. This guide bridges evidence from recent protocol innovations to practical, reproducible workflows in cancer and regenerative medicine research.

• Biotin-16-UTP: Advancing lncRNA Discovery and Translational

  2026-04-30

  This thought-leadership article explores how Biotin-16-UTP is reshaping RNA labeling for high-impact translational research, with a focus on long non-coding RNA (lncRNA) biology, mechanistic innovation in RNA detection and purification, and actionable guidance for researchers pursuing biomarker discovery. By integrating mechanistic insight with evidence from recent studies—including the pivotal identification of RNASEH1-AS1 as a prognostic biomarker in hepatocellular carcinoma—this piece provides a uniquely strategic perspective for deploying biotin-labeled uridine triphosphate in next-generation RNA-centric workflows.

• Spatially Localized BDNF Release Regulates NMJ Postsynaptic

  2026-04-29

  This study uncovers how muscle-generated BDNF is spatially trafficked and locally released to orchestrate the development of postsynaptic acetylcholine receptor clusters at neuromuscular junctions (NMJs). Using live-cell imaging and gene knockout models, the authors link precise BDNF localization and proteolytic processing—including matrix metalloproteinase (MMP) activity—to early synaptic architecture, revealing new mechanisms for synaptic assembly and potential intervention points.

• Nanoparticle-Mediated PTEN mRNA Reverses Trastuzumab Resista

  2026-04-29

  This study introduces a nanoparticle-based system for systemic delivery of PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer. By restoring PTEN expression and suppressing the PI3K/Akt pathway, this approach offers a mechanistically targeted strategy with translational potential for resistant cancer models.

• Cell Tumbling Drives Stem Cell Fate via Nuclear Mechanotrans

  2026-04-28

  This study introduces 'cell tumbling'—a rapid, 3D movement of stem cells within hydrogels—as a previously unrecognized driver of stem cell differentiation, mediated by nuclear mechanotransduction. The authors demonstrate that accelerating or inhibiting tumbling significantly alters chromatin accessibility and differentiation, providing new mechanistic insight and prompting re-evaluation of hydrogel design in tissue engineering.

• Hoechst 33258: Precision Bis-Benzimide DNA Stain for Cell An

  2026-04-28

  Hoechst 33258 from APExBIO empowers high-fidelity DNA visualization in both live and fixed cells, excelling in quantitative cell cycle analysis and AT-rich sequence targeting. Applied insights from recent tumor microenvironment studies reveal how this dye streamlines workflows in complex, pH-sensitive cytometric and microscopy applications.

• Estradiol Benzoate: Precision Tools for Estrogen Receptor Al

  2026-04-27

  Estradiol Benzoate sets the gold standard for estrogen receptor alpha (ERα) signaling research with high affinity and purity, enabling precise hormone receptor binding assays and advanced endocrinology workflows. This article distills practical protocols, troubleshooting strategies, and translational insights for maximizing your experimental outcomes.

• BRD4770 (SKU B4837): Reliable G9a Histone Methyltransferase

  2026-04-27

  This article delivers a scenario-driven, evidence-based guide to leveraging BRD4770 (SKU B4837) as a G9a histone methyltransferase inhibitor in cancer biology research. It addresses common laboratory pain points, protocol nuances, and product selection, highlighting validated parameters and workflow optimizations. Researchers gain practical insight into BRD4770’s data-backed reproducibility and vendor reliability for rigorous experimental outcomes.

• Assessing Ribociclib–Acid Reducer Interactions: QbD-Based Ev

  2026-04-26

  This study applied a Quality by Design (QbD) approach to evaluate the potential pharmacokinetic interaction between ribociclib, a CDK4/6 inhibitor, and acid-reducing agents commonly co-administered in cancer care. The investigation found that clinically relevant pH shifts caused by these agents do not significantly impact ribociclib’s solubility or absorption, clarifying a key uncertainty in oncology pharmacotherapy.

• Precision Nanoparticle Delivery of Doxycycline for AAA Thera

  2026-04-25

  This study introduces a bioactive tea polyphenol nanoparticle platform for precision delivery of doxycycline to abdominal aortic aneurysm (AAA) lesions. By enabling targeted, ROS-responsive drug release and synergistic antioxidant activity, the approach addresses major limitations of conventional therapies and offers a promising direction for non-surgical AAA management.

• Tacalcitol Monohydrate Induces NGF in Human Keratinocytes

  2026-04-24

  This study demonstrates that tacalcitol monohydrate, a synthetic analog of vitamin D3, induces nerve growth factor (NGF) expression in human epidermal keratinocytes via transcriptional activation. The findings provide mechanistic insight into potential topical strategies for modulating peripheral neuropathy and inform the use of vitamin D analogs in dermatology research.

• Eltanexor Modulates Wnt/β-catenin to Suppress Colorectal Tum

  2026-04-24

  This study demonstrates that Eltanexor (KPT-8602), a selective XPO1 inhibitor, modulates the Wnt/β-catenin signaling pathway, reduces COX-2 expression, and significantly decreases tumor burden in a colorectal cancer mouse model. The findings highlight a mechanistically distinct approach for chemoprevention in high-risk colorectal cancer populations and provide robust preclinical evidence to support further translational research.

• Itaconic Acid-Mediated TBK1 Alkylation Modulates IFN Respons

  2026-04-23

  Chai et al. reveal that itaconic acid, produced via the IRG1 pathway, directly alkylates TBK1 at Cys605, suppressing dimerization and type I interferon (IFN-I) signaling. The study introduces novel itaconic acid-derived inhibitors as potential tools for dampening pathological IFN-I responses, bridging cellular metabolism and innate immunity.

16147 records 1/1077 page Next 12345 下5页 Last page